Shanghai MicroPort Endovascular MedTech Co., Ltd. (SHA:688016)

Market Cap	12.57B +15.4%
Revenue (ttm)	1.39B +17.6%
Net Income	588.53M +31.5%
EPS	4.88 +34.8%
Shares Out	120.84M
PE Ratio	21.30
Forward PE	19.98
Dividend	2.30 (2.16%)
Ex-Dividend Date	n/a

Volume	210,132
Average Volume	1,990,389
Open	104.05
Previous Close	103.99
Day's Range	103.68 - 105.27
52-Week Range	84.10 - 124.30
Beta	0.19
RSI	54.41
Earnings Date	Apr 30, 2026

About SHA:688016

Shanghai MicroPort Endovascular MedTech Co., Ltd. engages in the research and development, manufacturing, sale, and services of aortic, peripheral vascular, and tumor intervention devices in China and internationally. The company offers Fontus, a branched stent graft system in surgical operation; CRONUS, a stent graft system in surgical operation; Hector, a multi-branch thoracic stent graft system; Cratos and Castor, a branched aortic stent graft system; Talos, a thoracic stent graft system; and Hercules, a thoracic stent graft system with low ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2012
• Employees: 822
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688016

Financial Performance

In 2025, SHA:688016's revenue was 1.35 billion, an increase of 11.96% compared to the previous year's 1.21 billion. Earnings were 563.33 million, an increase of 12.19%.